FDA Inspection 906758 — Fresenius Kabi Austria Gmbh
The FDA completed an inspection of Fresenius Kabi Austria Gmbh on Nov 7, 2014 in Linz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linz (Austria)